{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.218","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.117.1.7.1.218/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.218","version":"eCQM Update 2020-05-07","name":"UnfractionatedHeparin","title":"Unfractionated Heparin","status":"active","date":"2020-03-05","description":"(Clinical Focus: This value set contains concepts that represent heparin formulations that could reasonably be used to treat venous thromboembolism as a continuous infusion.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive unfractionated heparin as an intravenous infusion.),(Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used for continuous infusion of heparin and achieve therapeutic levels.),(Exclusion Criteria: Excludes concentrations < 250 UNT/ML (except those representing premixed heparin infusion bags, per inclusion criteria).)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"1361607","display":"500 ML heparin sodium, porcine 40 UNT/ML Injection"},{"code":"1658717","display":"250 ML heparin sodium, porcine 100 UNT/ML Injection"},{"code":"1659195","display":"500 ML heparin sodium, porcine 50 UNT/ML Injection"},{"code":"1659197","display":"250 ML heparin sodium, porcine 50 UNT/ML Injection"}]}]}}